• Find People
  • Campus Map
  • PiratePort
  • A-Z
    • About
    • Submit
    • Browse
    • Login
    View Item 
    •   ScholarShip Home
    • Dissertations and Theses
    • Dissertations
    • View Item
    •   ScholarShip Home
    • Dissertations and Theses
    • Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of The ScholarShipCommunities & CollectionsDateAuthorsTitlesSubjectsTypeDate SubmittedThis CollectionDateAuthorsTitlesSubjectsTypeDate Submitted

    My Account

    Login

    Statistics

    View Google Analytics Statistics

    Modulation of experimental autoimmune myocarditis with cytokine-myosin fusion proteins and novel cardiac peptides

    Thumbnail
    View/ Open
    408209_pdf_429016_2F2A8444-E255-11E5-B443-70BE4D662D30.pdf (3.589Mb)

    Show full item record
    Author
    Reece, Shaun Patrick
    Abstract
    Infectious agents that induce cross-reactive myocarditic T cell responses may cause autoimmune inflammation of the heart, dilated cardiomyopathy (DCM), and heart failure. The purpose of this study was to evaluate the efficacy of GMCSF-Myosin fusion proteins as tolerogenic vaccines capable of inhibiting experimental autoimmune myocarditis (EAM). The fusion proteins were comprised of an N-terminal granulocyte macrophage-colony stimulating factor (GM-CSF) domain and a C-terminal cardiac myosin antigen domain. The antigenic domains Myosin 1052-1076 and Myosin 614-643 were chosen based on epitopes known to cause EAM in Lewis rats and BALB/c mice, respectively. Bioactivity of the cytokine domains for GMCSF-Myo1052 and GMCSF-Myo614 were confirmed with bone marrow proliferation assays. Enhanced antigen presentation was confirmed for GMCSF-Myo1052. Both fusion proteins were found to inhibit disease progression when given as a pretreatment before EAM induction. When administered after disease induction, GMCSF-Myo614 reduced the incidence of EAM. To investigate the mechanisms of these tolerogenic vaccines, a model of EAM was developed in C57BL/6 mice by evaluating a peptide (myosin 718-736) derived from the murine cardiac alpha myosin heavy chain and theorized to bind to H2-I-Ab. EAM was successfully induced in Interferon gamma receptor knockout (Ifgr1-/- ) mice on the C57BL/6 background. Defining the mechanisms by which Interferon-gamma (IFN-[gamma]) inhibits EAM on the C57BL/6 background is beyond the scope of this project, but it is hypothesized that T cell apoptosis or induction of T regulatory cells is involved. In conclusion, this study demonstrated the feasibility of using GMCSF-Myosin fusion proteins to inhibit EAM, and provides a new model of EAM on C57BL/6 background to explore the mechanisms by which GMCSF-Myosin fusion proteins mediate tolerance.
    URI
    http://hdl.handle.net/10342/6077
    Subject
     Experimental autoimmune myocarditis; Fusion proteins; Cardiac peptides 
    Date
    2016-05-16
    Citation:
    APA:
    Reece, Shaun Patrick. (May 2016). Modulation of experimental autoimmune myocarditis with cytokine-myosin fusion proteins and novel cardiac peptides. , (. Retrieved from http://hdl.handle.net/10342/6077

    Display/Hide MLA, Chicago and APA citation formats.

    MLA:
    Reece, Shaun Patrick. "Modulation of experimental autoimmune myocarditis with cytokine-myosin fusion proteins and novel cardiac peptides". . . (.), May 2016. August 11, 2022. http://hdl.handle.net/10342/6077.
    Chicago:
    Reece, Shaun Patrick, "Modulation of experimental autoimmune myocarditis with cytokine-myosin fusion proteins and novel cardiac peptides,"  , no. (May 2016), http://hdl.handle.net/10342/6077 (accessed August 11, 2022).
    AMA:
    Reece, Shaun Patrick. Modulation of experimental autoimmune myocarditis with cytokine-myosin fusion proteins and novel cardiac peptides. . May 2016; () . http://hdl.handle.net/10342/6077. Accessed August 11, 2022.
    Collections
    • Dissertations
    • Physiology

    xmlui.ArtifactBrowser.ItemViewer.elsevier_entitlement

    East Carolina University has created ScholarShip, a digital archive for the scholarly output of the ECU community.

    • About
    • Contact Us
    • Send Feedback